Zobrazeno 1 - 10
of 281
pro vyhledávání: '"P. A. Panevin"'
Autor:
Taras S. Panevin, Roman V. Rozhivanov, Evgeniy G. Zotkin, Anastasia S. Avdeeva, Svetlana I. Glukhova
Publikováno v:
Терапевтический архив, Vol 96, Iss 5, Pp 486-493 (2024)
Aim. To study the frequency of hypogonadism (HG) in men with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA) and to evaluate the impact of HG on the course of RA and and concomitant diseases. Materials and meth
Externí odkaz:
https://doaj.org/article/8d7617a90cd34b05a2c52e6588190e5f
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 2, Pp 135-144 (2024)
Glucagon-like peptide-1 receptor agonists (ArGLP-1) are effective drugs for the treatment of type 2 diabetes mellitus and obesity. Recent studies in patients with a wide range of immunoinflammatory diseases suggest important pleiotropic mechanisms of
Externí odkaz:
https://doaj.org/article/9674c9cb24dd4e93a6dc9f8abd6e49bf
Publikováno v:
Современная ревматология, Vol 18, Iss 1, Pp 95-100 (2024)
Contraception is an important aspect of reproductive health in patients with rheumatic diseases. This is primarily due to the fact that in most immuneinflammatory rheumatic diseases (IRD) pregnancy must be planned. On one hand, the presence and activ
Externí odkaz:
https://doaj.org/article/1c12e540fc4d42f1a907250fd6ec95f5
Publikováno v:
Гинекология, Vol 25, Iss 4, Pp 428-434 (2023)
Premature ovarian insufficiency (POI) is a clinical syndrome defined as loss of ovarian function before the age of 40 years. Among the causes of POI are genetic, metabolic disorders, as well as infectious or iatrogenic factors, but in some cases the
Externí odkaz:
https://doaj.org/article/5d7fcdb3f375442e84f3de59019624bb
Publikováno v:
Терапевтический архив, Vol 95, Iss 10, Pp 881-887 (2023)
Autoimmune polyglandular syndromes (APS) are a heterogeneous group of clinical conditions characterized by functional impairment of multiple endocrine glands due to loss of central or peripheral immune tolerance. These syndromes are also often accomp
Externí odkaz:
https://doaj.org/article/3a837873f949437498a2ca0bf77c029f
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 5, Pp 545-553 (2023)
Rituximab is a chimeric (mouse and human) monoclonal antibody against B-lymphocytes (CD20). This drug is widely used in rheumatology in the treatment of rheumatoid arthritis, Sjogren’s syndrome, some systemic connective tissue diseases and vasculit
Externí odkaz:
https://doaj.org/article/e8ff66be35b1465cbb631b4ad2812b6b
Publikováno v:
Сахарный диабет, Vol 26, Iss 4, Pp 370-374 (2023)
IgG4-related disease (IgG4-RD) is characterized by the appearance of tumor-like foci in one or more organs, occurring synchronously or metachronously, due to fibro-inflammatory changes with hypersecretion of immunoglobulin G subclass 4 (IgG4) in tiss
Externí odkaz:
https://doaj.org/article/88d9d63197c44c818f60a59c02216a2f
Publikováno v:
Терапевтический архив, Vol 95, Iss 5, Pp 429-434 (2023)
Most rheumatic diseases are characterized by sexual dimorphism both in prevalence and in the characteristics of the clinical course. Increased production of pro-inflammatory cytokines that accompanies inflammatory joint diseases may be accompanied by
Externí odkaz:
https://doaj.org/article/4680c27011634524a114b63b86630906
Autor:
M. S. Eliseev, O. V. Zheliabina, E. L. Nasonov, E. V. Cheremushkina, T. A. Korotkova, T. S. Panevin
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 2, Pp 236-241 (2023)
Along with familial Mediterranean fever (FMF), it is now considered an autoinflammatory disease and gout. The commonality of the basic mechanisms of inflammation underlying the pathogenesis of FMF and gout predetermines the possibility of using simil
Externí odkaz:
https://doaj.org/article/501789b8a9df47149df9561bf3e88059
Autor:
A. S. Potapova, A. E. Karateev, E. Yu. Polishchuk, E. V. Matyanova, T. S. Panevin, A. S. Semashko, A. O. Bobkova, A. R. Khalmetova, E. S. Filatova, V. N. Amirjanova, A. M. Lila
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 2, Pp 214-219 (2023)
Central sensitization (CS) is a condition characterised by (associated with) neuroplastic changes in nociceptive neurons, sub-threshold afferent input, pain hypersensitivity and development widespread pain. Insufficient response to disease-modifying
Externí odkaz:
https://doaj.org/article/74645b093ce24a3d8d700870329a9f0f